Bell Investment Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52.2K | Buy |
668
+434
| +185% | +$33.9K | 0.01% | 238 |
|
|
2025
Q1 | $17K | Sell |
234
-89
| -28% | -$6.45K | ﹤0.01% | 433 |
|
|
2024
Q4 | $23.9K | Sell |
323
-3
| -0.9% | -$222 | ﹤0.01% | 345 |
|
|
2024
Q3 | $21.5K | Sell |
326
-19
| -6% | -$1.25K | ﹤0.01% | 385 |
|
|
2024
Q2 | $31.9K | Hold |
345
| – | – | 0.01% | 285 |
|
|
2024
Q1 | $33K | Sell |
345
-1
| -0.3% | -$96 | 0.01% | 275 |
|
|
2023
Q4 | $26.4K | Sell |
346
-121
| -26% | -$9.23K | 0.01% | 288 |
|
|
2023
Q3 | $32.4K | Sell |
467
-64
| -12% | -$4.43K | 0.01% | 231 |
|
|
2023
Q2 | $50.1K | Sell |
531
-14
| -3% | -$1.32K | 0.01% | 166 |
|
|
2023
Q1 | $45.1K | Buy |
545
+93
| +21% | +$7.69K | 0.01% | 174 |
|
|
2022
Q4 | $33.7K | Buy |
452
+96
| +27% | +$7.16K | 0.01% | 218 |
|
|
2022
Q3 | $29K | Buy |
356
+42
| +13% | +$3.42K | 0.01% | 198 |
|
|
2022
Q2 | $30K | Buy |
+314
| New | +$30K | 0.01% | 196 |
|
|
2021
Q4 | $49K | Buy |
381
+36
| +10% | +$4.63K | 0.01% | 161 |
|
|
2021
Q3 | $39K | Buy |
+345
| New | +$39K | 0.01% | 174 |
|